Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Journal of Cellular Physiology
|
February 24, 2011
Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro
M D Cantley, D P Fairlie, P M Bartold, et al.
Scientific Reports
|
November 30, 2016
Product release is rate-limiting for catalytic processing by the Dengue virus protease
A E Shannon, M M Pedroso, K J Chappell, et al.
Biochemical Pharmacology
|
June 1, 1997
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells
P G Parsons, C Hansen, D P Fairlie, et al.
British Journal of Pharmacology
|
May 14, 2014
Pathway-selective antagonism of proteinase activated receptor 2
J Y Suen, A Cotterell, R J Lohman, et al.
British Journal of Pharmacology
|
July 17, 2016
Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2
T Lieu, E Savage, P Zhao, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
Pharmacological Research
|
December 21, 2016
Mapping transmembrane residues of proteinase activated receptor 2 (PAR<sub>2</sub>) that influence ligand-modulated calcium signaling
J Y Suen, M N Adams, J Lim, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2008
Potent antimalarial activity of histone deacetylase inhibitor analogues
K T Andrews, T N Tran, A J Lucke, et al.
The Journal of Biological Chemistry
|
August 7, 1999
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion
R A Cherny, J T Legg, C A McLean, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing
D P Fairlie, J D Tyndall, R C Reid, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Journal of Cellular Physiology
|
February 24, 2011
Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro
M D Cantley, D P Fairlie, P M Bartold, et al.
Scientific Reports
|
November 30, 2016
Product release is rate-limiting for catalytic processing by the Dengue virus protease
A E Shannon, M M Pedroso, K J Chappell, et al.
Biochemical Pharmacology
|
June 1, 1997
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells
P G Parsons, C Hansen, D P Fairlie, et al.
British Journal of Pharmacology
|
May 14, 2014
Pathway-selective antagonism of proteinase activated receptor 2
J Y Suen, A Cotterell, R J Lohman, et al.
British Journal of Pharmacology
|
July 17, 2016
Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2
T Lieu, E Savage, P Zhao, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
Pharmacological Research
|
December 21, 2016
Mapping transmembrane residues of proteinase activated receptor 2 (PAR<sub>2</sub>) that influence ligand-modulated calcium signaling
J Y Suen, M N Adams, J Lim, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2008
Potent antimalarial activity of histone deacetylase inhibitor analogues
K T Andrews, T N Tran, A J Lucke, et al.
The Journal of Biological Chemistry
|
August 7, 1999
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion
R A Cherny, J T Legg, C A McLean, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing
D P Fairlie, J D Tyndall, R C Reid, et al.
Page
of 8